Filed before 2025Filed 9 February 2018
Syros Pharmaceuticals, Inc. has sold $11.4M so far
Syros Pharmaceuticals, Inc., a biotech company based in Cambridge, MA, has sold $11.4M so far in its equity round, according to a filing dated 9 February 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 9 February 2018
- First filed
- 17 January 2018
- Round
- Equity round (amended filing)
- Amount sold
- $11.4M
- Offering size
- $11.4M
- Investors so far
- 1
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 66% of the 1,729 tracked raises with an amount filed in 2018, and than 48% of the 160 in biotech.
Syros Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Dec 2020 | New filing | $90.5M | Another raise |
| 9 Feb 2018 | Amended filing | $11.4M | This raise |
| 17 Jan 2018 | New filing | $10M | This raise |
| 24 Oct 2014 | New filing | $53.1M | Another raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.